|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 246.27 USD | -1.16% |
|
-4.65% | +4.66% |
Share class: Alnylam Pharmaceuticals, Inc.
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 128,980,917 | 128,426,080 ( 99.57 %) | 0 | 99.57 % |
Major shareholders: Alnylam Pharmaceuticals, Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
Capital Research & Management Co. (World Investors)
12.80
%
| 16,508,424 | 12.80 % | 3 885 M $ |
Fidelity Management & Research Co. LLC
11.38
%
| 14,671,984 | 11.38 % | 3 452 M $ |
Vanguard Fiduciary Trust Co.
9.796
%
| 12,635,096 | 9.796 % | 2 973 M $ |
BlackRock Advisors LLC
6.296
%
| 8,120,653 | 6.296 % | 1 911 M $ |
Capital Research & Management Co. (Global Investors)
4.066
%
| 5,243,903 | 4.066 % | 1 234 M $ |
Wellington Trust Co., NA
3.840
%
| 4,953,347 | 3.840 % | 1 166 M $ |
Baillie Gifford & Co.
3.789
%
| 4,887,000 | 3.789 % | 1 150 M $ |
Capital Research & Management Co. (International Investors)
3.079
%
| 3,970,863 | 3.079 % | 934 M $ |
Dodge & Cox
2.809
%
| 3,622,535 | 2.809 % | 852 M $ |
State Street Corp.
2.689
%
| 3,468,315 | 2.689 % | 816 M $ |
| ░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
| Institutional | 81.43% |
| Other | 11.06% |
| State Street Corp. | 2.69% |
| Individuals | 0.40% |
| Schweizerische Nationalbank | 0.29% |
| Polar Capital Holdings Plc | 0.24% |
| Sumitomo Mitsui Trust Group, Inc. | 0.22% |
| SEI Investments Co. | 0.20% |
| Manulife Financial Corp. | 0.15% |
| Skandinaviska Enskilda Banken AB | 0.12% |
| Governments | 0.07% |
| Swedbank AB | 0.04% |
| Banco Bilbao Vizcaya Argentaria SA | 0.02% |
| Nomura Holdings, Inc. | 0.01% |
| Cullen/Frost Bankers, Inc. | 0.01% |
| The Bank of Nova Scotia | 0.01% |
| Unknown | 3.04% |
Based on 1000 largest holdings
Geographical origin of shareholders
| United States | 76.37% |
| United Kingdom | 10.75% |
| Norway | 1.87% |
| Switzerland | 1.63% |
| Canada | 1.42% |
| Bermuda | 0.98% |
| Germany | 0.58% |
| Japan | 0.56% |
| Sweden | 0.51% |
| Individuals | 0.40% |
| Australia | 0.36% |
| Luxembourg | 0.32% |
| South Korea | 0.24% |
| France | 0.21% |
| Denmark | 0.16% |
| Ireland | 0.16% |
| Spain | 0.08% |
| Singapore | 0.08% |
| Netherlands | 0.07% |
| China | 0.06% |
| Belgium | 0.03% |
| Austria | 0.02% |
| Taiwan | 0.02% |
| Finland | 0.02% |
| South Africa | 0.02% |
| Italy | 0.02% |
| Hong Kong | 0.01% |
| Israel | 0.01% |
Based on 1000 largest holdings
Employees
2,100
Sector
Pharmaceuticals
Calendar
05/02/2025
- Q4 2024 Earnings Release (Projected)
- Stock Market
- Equities
- ALNY Stock
- Company Alnylam Pharmaceuticals, Inc.
- Share ownership
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition